IPO News Archive

China-based orthopedic implant provider China Kanghui sets IPO terms

7/28/10


China Kanghui Holdings, which is a leading China-based manufacturer and marketer of orthopedic implants, announced terms for its IPO on Wednesday. The Changzhou-based company plans to raise $68 million by offering 6.7 million ADSs at a price range of $9.25-$11.25. At the mid-point of the proposed range, China Kanghui will command a market value of $223 million. China Kanghui, which was founded in 1997 and booked $29 million in sales for the 12 months ended March 31, plans to list on the NYSE under the symbol KH. Morgan Stanley and Piper Jaffray are the lead underwriters on the deal, which is expected to price during the week of August 9.

View IPO Profile: KH         
Related Links: Upcoming IPOs
Source: www.RenaissanceCapital.com
Latest User Comments
Attribution Policy: The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital, Greenwich, CT (www.renaissancecapital.com).
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital and/or the IPO Plus Fund (symbol: IPOSX) may have investments in securities of companies mentioned.
Invest in the IPO Plus Fund
About Fund Prospectus Invest